Low LDL Cholesterol Linked to Incidence of Cancer: New Study
Cholesterol-lowering drugs have long been employed to reduce the risk of heart disease, but they may also pose a risk of cancer, according to a new study in the Journal of the American College of Cardiology. According to research based on an evaluation of more than 41,000 cases, low levels of low-density lipoprotein (LDL) cholesterol have been associated with an increased incidence of cancer, as well as liver and muscle toxicity. The findings give rise to new concerns regarding the relative necessity and benefits of pharmaceutical cholesterol treatment. Researchers note that the study is not definitive, and further research is warranted. Specifically, it is not clearly understood whether the perceived cancer risk is related primarily to low LDL cholesterol levels, or to the statins prescribed in order to lower the LDL levels.
You should always consult your physician before beginning or discontinuing any medical treatment.
Previously on the D.C. Metro Area Medical Malpractice Law Blog, we posted an article concerning public health interventions that have lowered heart disease rates.
For information about your legal rights, please click here or call the law firm of Regan Zambri & Long, PLLC at 202-463-3030.